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Mammalian cells require oxygen for essentially all 
aspects of metabolism during both embryonic 
development and adult life [1].  Yet, in vivo, 
mammalian cells experience a wide range of oxygen 
concentrations, depending on the tissue type, proximity 
of cells to major arterioles and capillaries, and 
pathological conditions such as blood vessel occlusions, 
other sources of ischemia and neoplasia.  Cells have 
therefore evolved programmed responses to very low 
oxygen concentrations, or hypoxia, which helps them 
withstand hypoxic environments.  Hypoxic responses 
have traditionally been view as survival mechanisms 
that are essential for the proper function of cells that 
reside in naturally low oxygen tissue environments -- 
and for the survival of cells challenged by pathological 
ischemia.  Now, new findings by the Blagosklonny 
laboratory [2] uncover a novel, non-canonical role for 
hypoxia in determining whether cells enter a state of 
quiescence or senescence.  These findings have 
particular importance for certain stem cells, such as 
those in the relatively hypoxic niches of the bone 
marrow or tumor masses, and hence for a variety of 
diseases [3], especially those associated with aging.   
 
The Blagosklonny group used a cancer cell line that 
ceases division upon inducible, ectopic expression of 
the cell cycle inhibitor p21.  They previously showed 
that this induced expression rapidly arrests cell 
proliferation.  The arrest is reversible for 2-3 days – that 
is, by all criteria, it would be classified as quiescence, 
the reversibly arrested state in which many cells reside 
in vivo.  Thereafter, however, the arrest becomes 
irreversible and closely resembles the state termed 
cellular senescence.  Senescence is a double-edged 
sword [4].  It protects organisms from cancer by 
arresting the growth of cells at risk for neoplastic 
transformation, and may be beneficial under some 
conditions of tissue injury.  But the senescence response 
also entails a senescence-associated secretory 
phenotype (SASP): the secretion of numerous pro-
inflammatory cytokines.  The SASP can fuel chronic 
inflammation -- a major cause or contributor to many 
age-related pathologies, including cancer [4].  Thus,  the  
 
 










ectopic p21 expression causes cells to switch between 
two distinct states: initially, it induces quiescence, 
which converts to senescence after a few days.  The 
Blagonsklonny group terms this process 
geroconversion.   
 
The new paper [2] shows that under hypoxia -- 0.2% 
oxygen, which is significantly below the oxygen levels 
found in most, though not all, normal tissues [1] – 
ectopic p21 expression failed to cause geroconversion.  
That is, hypoxia prevented the conversion from 
quiescence to senescence.  This finding was not limited 
to the p21-inducible cancer cells; it was also seen in 
immortal but non-tumorigenic human fibroblasts and 
normal human retinal pigment epithelial (RPE) cells, 
both induced to senesce by the DNA damaging agent 
etoposide.  It is significant that hypoxia protected RPE 
cells from geroconversion: the senescence of these cells 
in vivo is thought to cause or contribute to age-related 
macular degeneration [5].   
 
Of particular interest, hypoxia resembled the effects of 
rapapmycin, a macrolide antibiotic that is currently in 
clinical use, mainly to prevent organ transplant 
rejection.  Rapamycin is a potent inhibitor of selected 
activities of the mTOR protein kinase, which defines an 
important pathway that drives aging in diverse 
eukaryotic organisms [6].  The Blagosklonny group 
previously showed that rapamycin also inhibits 
geroconversion [7].  Thus, their recent findings strongly 
suggest that rapamycin and hypoxia converge on the 
same pathway and mechanism – inhibition of mTOR 
activity.  Consistent with this hypothesis, hypoxia, 
much like rapamycin, suppressed phosphorylation of 
the S6 ribosomal protein, a major mTOR substrate.   
 
The effects of hypoxia in inhibiting geroconversion 
were independent of p53, which can also inhibit the 
mTOR pathway.  Remarkably, the effects were also 
independent of HIF-1, the transcription factor that is 
responsible for inducing the majority of hypoxia-
induced changes in gene expression.  This finding is in 
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hyperoxic conditions; under those conditions and in 
mouse fibroblasts, HIF-1 delays replicative senescence, 
largely through the induction of macrophage inhibitory 
factor (MIF) [8].  Thus, hypoxia appears to inhibit the 
transition from quiescence to senescence by a non-
canonical mechanism that is independent of both p53 
and HIF-1.   
 
What is the physiological significance of the findings 
that hypoxia, like rapamycin, inhibits the quiescence to 
senescence conversion?  One interesting possibility is 
that these findings define a mechanism by which stem 
cells that reside in a relatively hypoxic environment are 
able to survive and, importantly, persist in a quiescent 
state in order to be available for tissue repair and 
regeneration.  This protective effect of hypoxia may be 
particularly important for incidences of severe 
genotoxic stress, such as that experienced by patients 
undergoing radio- or chemo-therapy or survivors of 
environmental disasters.  In these cases, it would be 
advantageous to protect stem cells from senescence – a 
common response to genotoxic stress [4] –to ensure 
their availability for tissue repair and regeneration 
during recovery from the stress.  On the negative side, 
these new findings suggest hypoxia can also protect 
cancer stem cells from undergoing senescence in 
response to genotoxic therapies, and thus increase the 
probability of cancer recurrence.  In either case, these 
intriguing findings open the way for developing 
strategies to either stimulate or prevent senescence by 
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